These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 573399)

  • 1. Bromocriptine: decreased clinical effects at higher dosages.
    Koller WC; Weiner WJ; Nausieda PA; Klawans HL
    Neurology; 1979 Oct; 29(10):1439-40. PubMed ID: 573399
    [No Abstract]   [Full Text] [Related]  

  • 2. Low dose bromocriptine in Parkinson disease. Effects on the clinical picture and hypophyseal hormones.
    Plascencia-Fuentes JM; Cabañas-García A; Corona-Vázquez T; Estañol-Vidal B; López-Mora M; Zárate-Treviño A
    Arch Invest Med (Mex); 1986; 17(2):135-46. PubMed ID: 3592889
    [No Abstract]   [Full Text] [Related]  

  • 3. Bromocriptine dose and severity of Parkinson's disease.
    Grimes JD
    Neurology; 1985 Apr; 35(4):614-5. PubMed ID: 3982659
    [No Abstract]   [Full Text] [Related]  

  • 4. Bromocriptine and domperidone in the treatment of Parkinson disease.
    Quinn N; Illas A; Lhermitte F; Agid Y
    Neurology; 1981 Jun; 31(6):662-7. PubMed ID: 7195483
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low dosages of bromocriptine added to levodopa in Parkinson's disease.
    Hoehn MM; Elton RL
    Neurology; 1985 Feb; 35(2):199-206. PubMed ID: 3969207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bromocriptine long acting (LA) 50 mg intramuscular (IM) for the on-off phenomenon in Parkinson's disease.
    Staal-Schreinemachers AL; Lakke JP
    Acta Neurol Scand; 1987 Jun; 75(6):441. PubMed ID: 3630640
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute study of the association of bromocriptine and domperidone in parkinsonism (author's transl)].
    Pollak P; Gaio JM; Hommel M; Pellat J; Chateau R
    Therapie; 1981; 36(6):671-6. PubMed ID: 7342355
    [No Abstract]   [Full Text] [Related]  

  • 8. [Comparison of administration of low doses of bromocriptine and levodopa in the early treatment of Parkinson disease].
    Sternić N; Kostić V
    Srp Arh Celok Lek; 1992; 120(1-2):1-5. PubMed ID: 1641693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [L-dopa and bromocriptine in Parkinson disease. Early combination therapy has better effect].
    Olsson JE; Duchek M; Ekberg R; Fehling C; Johansson F; Johnels B; Lindvall B; Nordin G; Sidén A; Steg G
    Lakartidningen; 1993 Apr; 90(16):1545-8. PubMed ID: 8483351
    [No Abstract]   [Full Text] [Related]  

  • 10. Severity of Parkinson's disease and the dosage of bromocriptine.
    Larsen TA; Newman R; LeWitt P; Calne DB
    Neurology; 1984 Jun; 34(6):795-7. PubMed ID: 6539444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The treatment of Parkinson disease using the combination bromocriptine and levodopa].
    Dufresne JJ
    Rev Med Suisse Romande; 1990 Jun; 110(6):559-64. PubMed ID: 2367793
    [No Abstract]   [Full Text] [Related]  

  • 12. Bromocriptine in Parkinson's disease.
    Stern G; Lees A
    Br J Hosp Med; 1978 Dec; 20(6):666-70. PubMed ID: 743580
    [No Abstract]   [Full Text] [Related]  

  • 13. [Combined therapy of parkinsonism with bromocriptine, L-dopa and decarboxylase inhibitor (author's transl)].
    Vardy J; Rabey JM; Streifler M
    Harefuah; 1977 Sep; 93(5-6):129-33. PubMed ID: 924233
    [No Abstract]   [Full Text] [Related]  

  • 14. Bromocriptine: low-dose therapy in Parkinson disease.
    Teychenne PF; Bergsrud D; Racy A; Elton RL; Vern B
    Neurology; 1982 Jun; 32(6):577-83. PubMed ID: 7201089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Letter: Bromocriptine in parkinsonism.
    Debono AG; Donaldson I; Marsden CD; Parkes JD
    Lancet; 1975 Nov; 2(7942):987-8. PubMed ID: 53479
    [No Abstract]   [Full Text] [Related]  

  • 16. Bromocriptine in Parkinson disease: further studies.
    Lieberman AN; Kupersmith M; Gopinathan G; Estey E; Goodgold A; Goldstein M
    Neurology; 1979 Mar; 29(3):363-9. PubMed ID: 571981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of the on-off syndrome in Parkinsonism with low dose bromocriptine in combination with levodopa.
    Bateman DN; Coxon A; Legg NJ; Reid JL
    J Neurol Neurosurg Psychiatry; 1978 Dec; 41(12):1109-13. PubMed ID: 366085
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bromocriptine and lisuride in Parkinson's disease.
    Caraceni T; Giovannini P; Parati E; Scigliano G; Grassi MP; Carella F
    Adv Neurol; 1984; 40():531-5. PubMed ID: 6695632
    [No Abstract]   [Full Text] [Related]  

  • 19. Failure of oral administration of single rising doses of bromocriptine to produce acute anti-Parkinsonian effects.
    Poewe W; Schelosky L; Kleedorfer B
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):186-7. PubMed ID: 2019851
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjunctive therapy with bromocriptine in Parkinson's disease.
    Temlett JA; Ming A; Saling M; Fritz VU; Blumenfeld A; Bilchik TR; Becker AL; Fourie PB; Reef HE
    S Afr Med J; 1990 Dec; 78(11):680-5. PubMed ID: 2251616
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.